DM
KURA icon

Deerfield Management’s Kura Oncology KURA Stock Holding History

Deerfield Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,411,571
Closed -$106M – 273
2024
Q3 		$106M Hold
5,411,571
– – 1.58% 18
2024
Q2 		$111M Hold
5,411,571
– – 1.85% 14
2024
Q1 		$115M Buy
5,411,571
+98,838
+2% +$1.92M 2.01% 14
2023
Q4 		$76.4M Buy
5,312,733
+938,689
+21% +$9.23M 1.41% 22
2023
Q3 		$39.9M Buy
4,374,044
+1,136,044
+35% +$11.5M 0.88% 30
2023
Q2 		$34.3M Buy
3,238,000
+855,000
+36% +$10.1M 0.73% 34
2023
Q1 		$29.1M Hold
2,383,000
– – 0.65% 41
2022
Q4 		$29.6M Buy
2,383,000
+163,872
+7% +$2.38M 0.61% 48
2022
Q3 		$30.3M Sell
2,219,128
-407,872
-16% -$6.29M 0.6% 52
2022
Q2 		$48.2M Sell
2,627,000
-1,789,361
-41% -$25.7M 0.99% 36
2022
Q1 		$71M Buy
4,416,361
+902,605
+26% +$13M 1.59% 23
2021
Q4 		$49.2M Buy
3,513,756
+1,198,339
+52% +$19.4M 1.03% 33
2021
Q3 		$43.4M Buy
2,315,417
+521,417
+29% +$9.83M 0.85% 35
2021
Q2 		$37.4M Buy
+1,794,000
New +$44.5M 0.66% 50

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management's KURA Position: Q4 2024 in Review

Deerfield Management sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 5,411,571 shares — an estimated $106M sold.

Deerfield Management first reported a position in KURA in Q2 2021 and held it in 14 quarters. The position peaked at $115M in Q1 2024. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • Deerfield Management reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 5,411,571 Kura Oncology shares in Q4 2024, an estimated $106M.
  • Deerfield Management first reported a position in Kura Oncology in Q2 2021 and held it in 14 quarters.
  • Deerfield Management's Kura Oncology position peaked at $115M in Q1 2024.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.